On Rare Disease Day, February 29, 2024, EASL published European Association for the Study of the Liver Studio S6E6 – Alpha-1-antitrypsin deficiency (AATD): A poster child for genetic therapy
Guests Aftab Ala, our Alpha1 Germany advisor Pavel Strnad, and Alice Turner discuss the compelling reasons why AATD is a prime candidate for gene therapy. The presentation, moderated by Aleksander Krag, highlights the relevance of this topic in the current research landscape and points to ongoing global studies that are opening up new possibilities in this field.
